Clinical Trial Update: A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma. [Phase 1]

View source ↗

Summary

This is a Phase 1 trial update for IPM514 in patients with esophageal squamous cell carcinoma, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• IPM514

Snippet

Sponsor: Beijing Immupeutics Medicine Technology Limited | Conditions: Esophageal Squamous Cell Carcinoma | Phase 1 | Status: NOT_YET_RECRUITING